18 – 70
Smoker or non-smoker
BODY MASS INDEX (BMI)
A study to investigate a new drug being developed for the treatment of Clostridium Difficile Infections (CDI)
This study consists of a Screening Visit (to confirm your eligibility to enter the study)
One treatment period of approximately 2 days in duration. The treatment period will involve you staying at Simbec overnight from Day -1 until the morning of Day 2.
Return visits to the Clinical Unit on Days 3, 6, 8, 15, 22 and 29 for study assessments.
1 Follow Up Visit (Day 29)
Females interested in this study must be of non child bearing potential